What is LOPJLB’s current signal on SER?

LOPJLB’s latest quantitative signal on Serina Therapeutics, Inc. (SER) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is SER in?

Serina Therapeutics, Inc. (SER) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Serina Therapeutics, Inc. (SER) do?

Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond the…

Where is Serina Therapeutics, Inc. based / listed?

Serina Therapeutics, Inc. is based in US, listed on AMEX.

Serina Therapeutics, Inc. (SER)

Healthcare · Biotechnology · AMEX · US

$2.63-8.36%Close

BUYRECOVERY · day 40

[SCORES & PROFILE]

FUND: 13
VALUE: 0
GROWTH: 45
GARP: 5
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-133.5%

REV YoY-

ROE-222.4%

EPS YoY-

ROA-82.0%

GROSS

NET

[VALUATION]

P/E TTM-1.40

P/E FWD-

SECTOR PE22.66

INDUSTRY PE17.07

P/B2.30

P/FCF-

EV/EBITDA-0.89

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E17.13

ALTMAN Z-

CURR RATIO6.65

ND/EBITDA-

BETA0.03

Serina Therapeutics, Inc. (SER)

Key stats

Sector peers

Prediction markets

FUNDAMENTALS

Company news